Methods of use comprising a biocidal polyamine
US-9220267-B2 · Dec 29, 2015 · US
(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
US9108939B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9108939-B2 |
| Application number | US-201013504209-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2010 |
| Priority date | Oct 27, 2009 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives having the general formula (I) to pharmaceutical compositions comprising the same and to the use of these (1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)phenyl derivatives in the treatment of atherosclerosis.
First claim
Opening claim text (preview).
The invention claimed is: 1. A (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivative having the general Formula I wherein n is 1; X is NR 4 ; Y is O and the dotted bond represents a single bond; or Y has a meta or para substitution pattern on the phenyl ring in relation to the phenyl-NH position; Z is CH 2 ; the hexafluoroispopropanol substituent has a…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9108939B2 cover?
- The present invention relates to (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives having the general formula (I) to pharmaceutical compositions comprising the same and to the use of these (1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)phenyl derivatives in the treatment of atherosclerosis.
- Who is the assignee on this patent?
- Cooke Andrew John, Carswell Emma Louise, Bennett David Jonathan, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C07D295/135. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).